Global Pharmaceutical Excipients Market

Global Pharmaceutical Excipients Market

Analysis by Product Type (Organic Chemicals: Carbohydrates, Petrochemicals, Oleochemicals, Proteins; Inorganic Chemicals: Calcium Phosphates, Metal Oxides, Calcium Carbonate, Silicates, Halites), Functionality (Fillers and Diluents, Binders, Coating Agents, Disintegrants, Solubilizers and Emulsifiers, Lubricants and Glidants, Flavoring and Sweeteners, Preservatives, Others), Formulation (Oral, Parenteral, Topical, Others) and Region

Report ID: HP05 | Format: PDF, Excel | Publish Date: November 2026 | Pages: 120

1. Executive Summary
•    1.1 Key Findings
•    1.2 Market Snapshot: Value, Volume, Capacity and Price, 2025 and 2034
•    1.3 Analyst Viewpoint
2. Research Methodology
•    2.1 Research Scope and Market Definition
•    2.2 Data Sources: Primary and Secondary Research
•    2.3 Market Sizing Approach: Bottom-Up Production and Consumption Model
•    2.4 Capacity Mapping and Utilization Estimation
•    2.5 Price Estimation by Excipient Chemistry
•    2.6 Forecasting Assumptions and Data Triangulation
•    2.7 Abbreviations and Units
3. Global Pharmaceutical Excipients Market Outlook
•    3.1 Market Value, 2021–2034 (US$ Billion)
•    3.2 Consumption Volume, 2021–2034 ('000 Tons)
•    3.3 Installed Production Capacity, 2021–2034 ('000 Tons)
•    3.4 Production Output and Capacity Utilization, 2021–2034
•    3.5 Average Selling Price Trend, 2021–2034 (US$ per Ton)
4. Market Dynamics
•    4.1 Drivers
•    4.1.1 Migration of Generic and Contract Formulation Volume to Asia
•    4.1.2 Growth of Biologics, Peptides and Long-Acting Injectables
•    4.1.3 Rising Share of Poorly Soluble Molecules in Development Pipelines
•    4.2 Restraints
•    4.2.1 Absence of a Standalone Regulatory Pathway for Novel Excipients
•    4.2.2 Energy and Raw Material Cost Inflation
•    4.3 Opportunities
•    4.3.1 Co-Processed and Ready-to-Use Excipient Systems
•    4.3.2 Regional Supply Localization near Formulation Clusters
•    4.3.3 Low-Carbon and Sustainably Documented Excipients
•    4.4 Challenges
•    4.4.1 Single-Site Supply Concentration and Business Continuity Risk
•    4.4.2 Supplier Requalification Cost and Time
5. Pricing and Cost Structure Analysis
•    5.1 Average Price by Excipient Chemistry, 2025 vs 2034
•    5.2 Cost Structure: Raw Materials, Energy, Compliance and Logistics
•    5.3 Price Pass-Through and Switching Cost Dynamics
•    5.4 Recent Supplier Price Adjustments
6. Production Capacity and Supply Resilience
•    6.1 Installed Capacity by Region, 2025 vs 2034
•    6.2 Capacity Additions and Planned Expansions Tracker
•    6.3 Supply Disruption Case Analysis
•    6.4 Multi-Site Qualification and Dual-Sourcing Assessment
7. Global Market Analysis by Product Type
•    7.1 Organic Chemicals
•    7.1.1 Carbohydrates (Sugars, Starches, Cellulose and Derivatives)
•    7.1.2 Petrochemicals (Glycols, Povidones, Acrylic Polymers, Mineral Hydrocarbons)
•    7.1.3 Oleochemicals (Fatty Alcohols, Glycerin, Lipids)
•    7.1.4 Proteins (Gelatin and Others)
•    7.2 Inorganic Chemicals
•    7.2.1 Calcium Phosphates
•    7.2.2 Metal Oxides
•    7.2.3 Calcium Carbonate
•    7.2.4 Silicates
•    7.2.5 Halites
8. Global Market Analysis by Functionality
•    8.1 Fillers and Diluents
•    8.2 Binders
•    8.3 Coating Agents
•    8.4 Disintegrants
•    8.5 Solubilizers and Emulsifiers
•    8.6 Lubricants and Glidants
•    8.7 Flavoring Agents and Sweeteners
•    8.8 Preservatives
•    8.9 Others
9. Global Market Analysis by Formulation
•    9.1 Oral (Tablets, Capsules, Liquids)
•    9.2 Parenteral
•    9.3 Topical
•    9.4 Others (Inhalation, Ophthalmic, Nasal)
10. Regional Analysis (Value, Volume, Capacity, 2021–2034)
•    10.1 North America (U.S., Canada, Mexico)
•    10.2 Europe (Germany, France, Italy, U.K., Spain, Switzerland, Ireland, Rest of Europe)
•    10.3 Asia Pacific (China, India, Japan, South Korea, Australia, Southeast Asia, Rest of Asia Pacific)
•    10.4 Latin America (Brazil, Argentina, Rest of Latin America)
•    10.5 Middle East and Africa (GCC, South Africa, Rest of Middle East and Africa)
11. Regulatory Landscape
•    11.1 Pharmacopoeial Standards (USP–NF, Ph. Eur., JP, IP)
•    11.2 Excipient GMP and Certification Schemes
•    11.3 Novel Excipient Review Initiatives
•    11.4 Elemental Impurities and Nitrosamine Risk Controls
12. Competitive Landscape
•    12.1 Market Structure and Concentration
•    12.2 Recent Mergers, Acquisitions and Divestitures
•    12.3 Epignosis Insights Competitive Assessment Framework (EICAF)
•    12.4 EICAF Scoring Method and Company Rankings
13. Company Profiles
•    13.1 Roquette (incl. former IFF Pharma Solutions)
•    13.2 BASF Pharma Solutions
•    13.3 Ashland
•    13.4 Evonik Health Care
•    13.5 DFE Pharma
•    13.6 Colorcon
•    13.7 JRS Pharma
•    13.8 MEGGLE
•    13.9 Merck KGaA
•    13.10 Shin-Etsu Chemical
•    13.11 Lubrizol
•    13.12 Croda
•    13.13 Gattefossé
•    13.14 SPI Pharma (incl. former Elementis Pharma)
•    13.15 Asahi Kasei
•    13.16 Kerry
•    13.17 Wacker Chemie
•    13.18 Avantor
•    13.19 Sigachi Industries
•    13.20 Ideal Cures
•    Each profile: Company Overview, Excipient Portfolio, Manufacturing Footprint, Financial Snapshot, Recent Developments
14. Strategic Recommendations
•    14.1 For Excipient Manufacturers
•    14.2 For Pharmaceutical Formulators and Procurement Teams
•    14.3 For Investors
15. Appendix
•    15.1 List of Tables
•    15.2 List of Figures
•    15.3 Disclaimer

Frequently Asked Questions

What is the global pharmaceutical excipients market size in 2025?
The global pharmaceutical excipients market is valued at approximately US$9.94 billion in 2025, according to Epignosis Insights estimates.
What is the expected global pharmaceutical excipients market size by 2034?
The market is projected to reach approximately US$16.34 billion by 2034, representing a 5.7% CAGR from 2027 to 2034.
What is the global pharmaceutical excipients market volume?
Global excipient consumption is estimated at approximately 1,790 thousand tons in 2025, increasing to around 2,637 thousand tons by 2034.
What is the global production capacity for pharmaceutical excipients?
Installed global capacity is estimated at 2,240 thousand tons in 2025 and is forecast to reach 3,081 thousand tons by 2034, with utilization rising from 79.9% to 85.6%.
Which formulation segment is growing fastest?
Parenteral excipients are the fastest growing route, with a forecast CAGR of 7.6% between 2027 and 2034.

Small Analyst Support Card

Need Help Choosing the Right Report

Talk to Our Analyst